Progression in Cutaneous Malignant Melanoma Is Associated with Distinct Expression Profiles
Top Cited Papers
Open Access
- 1 January 2004
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 164 (1) , 193-203
- https://doi.org/10.1016/s0002-9440(10)63110-0
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Tissue microarrays (TMAs) for high-throughput molecular pathology researchInternational Journal of Cancer, 2001
- Analysis of MUM1/IRF4 Protein Expression Using Tissue Microarrays and ImmunohistochemistryLaboratory Investigation, 2001
- Genetic dissection of melanoma pathways in the mouseSeminars in Cancer Biology, 2001
- Dual Inactivation of RB and p53 Pathways in RAS-Induced MelanomasMolecular and Cellular Biology, 2001
- Expression and Targeting of the Apoptosis Inhibitor, Survivin, in Human MelanomaJournal of Investigative Dermatology, 1999
- Protein Expression of the Cell-Cycle Inhibitor p27Kip1 in Malignant Melanoma: Inverse Correlation with Disease-Free SurvivalThe American Journal of Pathology, 1998
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998
- Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]Human Molecular Genetics, 1998
- Model Predicting Survival in Stage I Melanoma Based on Tumor ProgressionJNCI Journal of the National Cancer Institute, 1989
- Thickness, Cross-Sectional Areas and Depth of Invasion in the Prognosis of Cutaneous MelanomaAnnals of Surgery, 1970